Soltis Investment Advisors LLC Merck & Co., Inc. Transaction History

Soltis Investment Advisors LLC

$1.38 Billion
Q3 2025

A detailed history of Soltis Investment Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 47,011 shares of MRK stock, worth $4.37 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

47,011

Previous 10,146 363.35%

Holding current value

$4.37 Million

Previous $803,000 391.28%

% of portfolio

0.29%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$77.6 - $87.37 $2.86 Million - $3.22 Million	36,865 Added 363.35%	47,011 $3.95 Million
Q2 2025 Aug 06, 2025	SELL	$73.47 - $87.12 $2 Million - $2.37 Million	-27,230 Reduced 72.85%	10,146 $803,000
Q1 2025 May 13, 2025	BUY	$83.01 - $101.02 $2.27 Million - $2.76 Million	27,349 Added 272.75%	37,376 $3.35 Million
Q4 2024 Jan 29, 2025	SELL	$96.31 - $114.76 $558,886 - $665,952	-5,803 Reduced 36.66%	10,027 $997,000
Q3 2024 Nov 18, 2024	SELL	$111.15 - $128.97 $5,779 - $6,706	-52 Reduced 0.33%	15,830 $1.8 Million

Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $15,475 - $16,620	125 Added 0.79%	15,882 $1.97 Million
Q1 2024 Apr 29, 2024	BUY	$113.24 - $131.95 $27,970 - $32,591	247 Added 1.59%	15,757 $2.08 Million
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $10,518 - $11,447	-105 Reduced 0.67%	15,510 $1.69 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $88,537 - $98,323	860 Added 5.83%	15,615 $1.61 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $577,044 - $628,952	5,313 Added 56.27%	14,755 $1.7 Million
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $823 - $918	-8 Reduced 0.08%	9,442 $1 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $2.97 Million - $3.81 Million	-33,951 Reduced 78.23%	9,450 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $205,492 - $230,847	2,431 Added 5.93%	43,401 $3.74 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $230,849 - $261,679	2,765 Added 7.24%	40,970 $3.74 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $578,450 - $648,405	7,869 Added 25.94%	38,205 $3.14 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $1.96 Million - $2.45 Million	27,066 Added 827.71%	30,336 $2.33 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $3,297 - $3,626	46 Added 1.43%	3,270 $246,000
Q2 2021 Aug 04, 2021	SELL	$70.31 - $77.77 $25,100 - $27,763	-357 Reduced 9.97%	3,224 $251,000
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $287,283 - $338,390	-4,172 Reduced 53.81%	3,581 $276,000
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $322,319 - $357,708	4,491 Added 137.68%	7,753 $634,000
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $248,446 - $281,615	-3,395 Reduced 51.0%	3,262 $271,000
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $260,554 - $296,481	3,700 Added 125.13%	6,657 $515,000
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $24,647 - $34,161	389 Added 15.15%	2,957 $228,000
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $199,225 - $224,802	2,568 New	2,568 $234,000

Others Institutions Holding MRK

# of Institutions

3,937

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.

Account

Soltis Investment Advisors LLC Merck & Co., Inc. Transaction History